We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
BIO-RAD LABORATORIES

Download Mobile App




Acute Kidney Injury and Chronic Kidney Disease Closely Entwined

By LabMedica International staff writers
Posted on 13 Jul 2014
Print article
Common risk factors of acute kidney injury (AKI) and chronic kidney disease (CKD) include advanced age, diabetes, and high blood pressure.

AKI is sudden loss of kidney function; CKD develops slowly over many years. A comprehensive analysis by scientists at the National Institutes of Health (NIH; Bethesda, MD, USA) and George Washington University Medical Center (Washington DC, USA) suggests that each disease is a risk factor for developing the other. They share other risk factors as well as causes for the diseases to become worse, and also outcomes. The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK; Bethesda, MD, USA) recommend that people with either disease should be monitored for both.

Analyzing large observational studies, the scientists saw that CKD and AKI were also risk factors for development of cardiovascular disease, progressive decreases in kidney function that can lead to kidney failure, diminished quality of life, disability, and premature death. The findings were published July 3, 2014, in the New England Journal of Medicine (NEJM).

The investigators found that new cases of AKI are increasing among hospitalized patients, possibly due to the aging population and rising rates of sepsis, a potentially life-threatening blood infection that can cause AKI. However, they found that preexisting CKD is the most important risk factor for AKI, increasing the odds by as much as 10 times. Conversely, patients with AKI had a 13-fold increased risk of CKD that progressed to kidney failure, compared to those without AKI. And the risk of kidney failure rose to 40 times if patients had both AKI and preexisting CKD.

Observational data in the 2007 US Renal Data System Annual Data Report suggest that few people with AKI see physicians and/or cardiologists after being discharged from hospital.

Paul Kimmel, MD, director of the Acute Kidney Injury program at the NIH's National Institute of Diabetes and Digestive and Kidney Diseases and lead author of the NEJM article, commented, "Physicians have been taught for decades to consider AKI and CKD as separate, but our study shows that we have to approach the two diseases as interconnected. When people have chronic kidney disease, their doctors should be on the lookout for acute kidney injury. And when people have recovered from acute kidney injury, they should promptly follow up with their doctor––and a kidney specialist to monitor their kidney function for long-term consequences related to progression of CKD."

The NIDDK, a component of the NIH, conducts and supports research on diabetes and other endocrine and metabolic diseases; digestive diseases, nutrition, and obesity; and kidney, urologic, and hematologic diseases. It covers the full range of medicine afflicting people of all ages and ethnic groups. These diseases represent some of the most common, severe, and disabling conditions affecting Americans.

Related Links:

National Institutes of Health
George Washington University Medical Center 
National Institute of Diabetes and Digestive and Kidney Diseases


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Real-time PCR System
GentierX3 Series

Print article

Channels

Molecular Diagnostics

view channel
Image: Signs of multiple sclerosis show up in blood years before symptoms appear (Photo courtesy of vitstudio/Shutterstock)

Unique Autoantibody Signature to Help Diagnose Multiple Sclerosis Years before Symptom Onset

Autoimmune diseases such as multiple sclerosis (MS) are thought to occur partly due to unusual immune responses to common infections. Early MS symptoms, including dizziness, spasms, and fatigue, often... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Microbiology

view channel
Image: Microscope image showing human colorectal cancer tumor with Fusobacterium nucleatum stained in a red-purple color (Photo courtesy of Fred Hutch Cancer Center)

Mouth Bacteria Test Could Predict Colon Cancer Progression

Colon cancer, a relatively common but challenging disease to diagnose, requires confirmation through a colonoscopy or surgery. Recently, there has been a worrying increase in colon cancer rates among younger... Read more

Pathology

view channel
Image: A new study has identified patterns that predict ovarian cancer relapse (Photo courtesy of Cedars-Sinai)

Spatial Tissue Analysis Identifies Patterns Associated With Ovarian Cancer Relapse

High-grade serous ovarian carcinoma is the most lethal type of ovarian cancer, and it poses significant detection challenges. Typically, patients initially respond to surgery and chemotherapy, but the... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.